SCHEMBL4491552

SCHEMBL4491552

NC(=O)c1ccc(Br)nc1Br

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NNMT P40261 1/20 0.43
DGAT1 O75907 1/20 0.42
ERN1 O75460 1/20 0.39
PARP1 P09874 2/20 0.36
KDM4E B2RXH2 4/20 0.35
ALDH1A1 P00352 3/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
IKBKB O14920 1/20 0.35
CDC7 O00311 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
KMT2A Q03164 3/20 0.34
ATM Q13315 1/20 0.34
SIRT3 Q9NTG7 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
PLK4 O00444 1/20 0.34
CHEK1 O14757 1/20 0.34
AURKA O14965 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29587695 0.80 CYP1A2 (0.44) KDM4EALDH1A1TSHRRXFP1TDP1
SCHEMBL2964431 0.80 CYP1A2 (0.44) KDM4EALDH1A1TSHRRXFP1TDP1
SCHEMBL29726667 0.79 DGAT1 (0.48) NNMTDGAT1ERN1PARP1KDM4E
SCHEMBL5557667 0.79 NNMT (0.62) NNMTDGAT1ERN1PARP1KDM4E
SCHEMBL21054675 0.79 DGAT1 (0.48) NNMTDGAT1ERN1PARP1KDM4E
SCHEMBL22993612 0.75 NNMT (0.41) NNMTDGAT1ERN1PARP1KDM4E
SCHEMBL428407 0.75 NNMT (0.53) NNMTDGAT1PARP1KDM4EALDH1A1
SCHEMBL22658874 0.74 L3MBTL1 (0.45) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL29587479 0.74 L3MBTL1 (0.45) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL15823157 0.72 PARP1 (0.42) NNMTDGAT1PARP1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632865-B2 Thioamides and salts thereof and cytokine production inhibitors containing both ISHIHARA SANGYO KAISHA, LTD. (JP) 2009-12-15 US disclosed
US-20070219215-A1 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both ISHIHARA SANGYO KAISHA, LTD (JP) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219215-A1 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both IFNG, TST, STAT6 NNMT 997/4885DGAT1 3695/4885ERN1 3241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.